Tragara Raises $5M

Xconomy San Diego — 

San Diego-based Tragara Pharmaceuticals, which has focused its current drug development on two compounds for treating tumors, has raised $5 million of a targeted $10 million venture round, according to a recent regulatory filing. The company raised $40 million in its Series A round in 2007. Tragara’s filing did not identify the investors in its current round, but the company’s website identifies its existing investors as Domain Associates, Mitsubishi, Morgenthaler Ventures, Oxford Bioscience Partners, and ProQuest Investments.